Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 


 
 Table of Contents  
REVIEW ARTICLE
Year : 2010  |  Volume : 6  |  Issue : 4  |  Page : 427-431

From tumor immunology to cancer immunotherapy: Miles to go


Departments of Oral Pathology and Microbiology, School of Dental Sciences, Sharda University, Greater Noida Uttar Pradesh, India

Date of Web Publication24-Feb-2011

Correspondence Address:
Manjul Tiwari
D-97, Anupam Apartments, B/13, Vasundhara Enclave, Delhi - 110096
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0973-1482.77071

Rights and Permissions
 > Abstract 

Advances in tumor immunology are supporting the clinical implementation of several immunological approaches to cancer in the clinical setting. However, the alternate success of current immunotherapeutic regimens underscores the fact that the molecular mechanisms underlying immune-mediated tumor rejection are still poorly understood. Given the complexity of the immune system network and the multidimensionality of tumor/host interactions, the comprehension of tumor immunology might greatly benefit from high-throughput microarray analysis, which can portrait the molecular kinetics of immune response on a genome-wide scale, thus accelerating the discovery pace and ultimately catalyzing the development of new hypotheses in cell biology. Although the general principles of microarray-based gene profiling with the application of DNA microarray have rapidly spread in the scientific community, the need for mastering this technique to produce meaningful data and correctly interpret the enormous output of information generated by this technology is critical and represents a tremendous challenge for investigators. To describe the sequence of events conductive to an effective immune recognition and killing of malignant cells, clinicians might use gene profiling as a powerful tool to assess the activation status of the immune system before and during immunotherapy.

Keywords: DNA microarray, immune-mediated tumors, microarray, tumor immunology


How to cite this article:
Tiwari M. From tumor immunology to cancer immunotherapy: Miles to go. J Can Res Ther 2010;6:427-31

How to cite this URL:
Tiwari M. From tumor immunology to cancer immunotherapy: Miles to go. J Can Res Ther [serial online] 2010 [cited 2019 Dec 5];6:427-31. Available from: http://www.cancerjournal.net/text.asp?2010/6/4/427/77071

The following article is been Retracted







This article has been cited by
1 Indoleamine 2,3-dioxygenase inhibitory activity of derivatives of marine alkaloid tsitsikammamine A
Eduard Dolušic,Pierre Larrieu,Céline Meinguet,Delphine Colette,Arnaud Rives,Sébastien Blanc,Thierry Ferain,Luc Pilotte,Vincent Stroobant,Johan Wouters,Benoît Van den Eynde,Bernard Masereel,Evelyne Delfourne,Raphaël Frédérick
Bioorganic & Medicinal Chemistry Letters. 2013; 23(1): 47
[Pubmed] | [DOI]
2 Elevated level of peripheral CD8+CD28- T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy
Guohong Song,Xiaoli Wang,Jun Jia,Yanhua Yuan,Fengling Wan,Xinna Zhou,Huabing Yang,Jun Ren,Jiezhun Gu,Herbert Kim Lyerly
Cancer Immunology, Immunotherapy. 2013; 62(6): 1123
[Pubmed] | [DOI]
3 Characteristics of New Monomolecular Chimeric T-Cell Receptors to Carcinoembryonic Antigen
V. K. Bozhenko,E. I. Shramova,A. M. Shishkin,A. V. Ivanov,E. V. Khokhlova,Yu. S. Lebedin,A. N. Shkoporov
Bulletin of Experimental Biology and Medicine. 2013;
[Pubmed] | [DOI]
4 Elevated level of peripheral CD8+CD28- T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy
Song, G. and Wang, X. and Jia, J. and Yuan, Y. and Wan, F. and Zhou, X. and Yang, H. and Ren, J. and Gu, J. and Lyerly, H.K.
Cancer Immunology, Immunotherapy. 2013; 62(6): 1123-1130
[Pubmed]
5 Indoleamine 2,3-dioxygenase inhibitory activity of derivatives of marine alkaloid tsitsikammamine A
Dolušić, E. and Larrieu, P. and Meinguet, C. and Colette, D. and Rives, A. and Blanc, S. and Ferain, T. and Pilotte, L. and Stroobant, V. and Wouters, J. and Van Den Eynde, B. and Masereel, B. and Delfourne, E. and Frédérick, R.
Bioorganic and Medicinal Chemistry Letters. 2013; 23(1): 47-54
[Pubmed]
6 Macrophage-tumor crosstalk: Role of TAMR tyrosine kinase receptors and of their ligands
Schmidt, T., Ben-Batalla, I., Schultze, A., Loges, S.
Cellular and Molecular Life Sciences. 2012; 69(9): 1391-1414
[Pubmed]
7 Macrophage–tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands
Thomas Schmidt,Isabel Ben-Batalla,Alexander Schultze,Sonja Loges
Cellular and Molecular Life Sciences. 2012; 69(9): 1391
[Pubmed] | [DOI]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  >Abstract
  In this article

 Article Access Statistics
    Viewed4440    
    Printed196    
    Emailed4    
    PDF Downloaded854    
    Comments [Add]    
    Cited by others 7    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]